Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice (ID 30)

Q&A (ID 372)

Lecture Time
13:10 - 13:20
Speakers
  • All Speakers (na, Swaziland)
Authors
  • All Speakers (na, Swaziland)
Room
Munich Hall
Date
Wed, 04.05.2022
Time
13:00 - 14:00